Attorney General Aaron Ford announced Wednesday afternoon that his office has reached a nearly $30 million settlement with drug manufacturer Glenmark.
The settlement is part of a multi-state antitrust case against the generic drug manufacturer. 48 U.S. states and territories allege Glenmark engaged in a conspiracy to artificially inflate prices and reduce competition on the sale of more than 100 medications.
That includes drugs used to treat asthma, cancer and diabetes, among other conditions.
Nevada will distribute $41,000 to impacted agencies and over $13 million to a consumer restitution fund.
Individual Nevadans who bought one of Glenmark’s products between May 2009 and December 2019 may also be eligible for monetary compensation. Members of the public can find more information about eligibility at aggenericdrugs.com.
